Phase 1 Clinical Trials of the National Institutes of Health Vaccine Research Center HIV/AIDS Candidate Vaccines
Overview
Authors
Affiliations
Synthetic DNA vaccine strategies against persistent viral infections.
Villarreal D, Talbott K, Choo D, Shedlock D, Weiner D Expert Rev Vaccines. 2013; 12(5):537-54.
PMID: 23659301 PMC: 4317298. DOI: 10.1586/erv.13.33.
Shete A, Thakar M, Tripathy S, Raut C, Chakrabarti S, Paranjape R J Glob Infect Dis. 2011; 3(3):246-53.
PMID: 21887056 PMC: 3162811. DOI: 10.4103/0974-777X.83530.
Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccine.
Arrode-Bruses G, Sheffer D, Hegde R, Dhillon S, Liu Z, Villinger F J Virol. 2009; 84(3):1243-53.
PMID: 19923181 PMC: 2812351. DOI: 10.1128/JVI.01846-09.
Nef modulates the immunogenicity of Gag encoded in a non-infectious HIV DNA vaccine.
Arrode G, Hegde R, Jin Y, Singh D, Narayan O, Chebloune Y Vaccine. 2008; 26(31):3795-804.
PMID: 18586360 PMC: 2519121. DOI: 10.1016/j.vaccine.2008.05.057.
Rodriguez A, Goudsmit J, Companjen A, Mintardjo R, Gillissen G, Tax D Infect Immun. 2008; 76(4):1709-18.
PMID: 18212075 PMC: 2292849. DOI: 10.1128/IAI.01614-07.